McKesson leverages ePA expertise in ExpressCoverage launch
ExpressCoverage is a new and powerful patient support platform launched Wednesday that connects patients, providers, payers and the life science industry to facilitate patient access and adherence for improved outcomes. The goal of ExpressCoverage is to help patients benefit from a seamless support system that improves access to medications, supports adherence and reduces prescription abandonment, ultimately resulting in better care delivery and superior patient outcomes.
“Patients are our No. 1 priority, and we are constantly looking for ways to improve their experience and access to medications, from the first discussion with their physician to the point of picking up the prescription, followed by ongoing education and adherence support,” Bill Nolan, vice president and general manager, McKesson Specialty Health, said. “The real-time connectivity between the CoverMyMeds’ network of providers, payers and pharmacies, and McKesson’s hub support services will reduce barriers to access, help patients start therapy quickly and stay on therapy longer.”
The offering is the result of a collaboration between McKesson Specialty Health, a division of McKesson Corporation, and CoverMyMeds, part of McKesson Rx Technology Solutions and a leader in electronic prior authorization solutions. Express Coverage leverages the prior authorization expertise of CoverMyMeds and the broad spectrum of high-touch biopharma-sponsored McKesson services to help physicians and patients better navigate the complexities of a specialty therapy journey.
“Prior authorization, when done manually, often results in treatment delays and gaps in therapy for patients. The prior authorization process impacts approximately 300 million prescriptions each year, and of those, roughly 36% are abandoned,” Erica Conroy, vice president operations, CoverMyMeds, said. “The integration of CoverMyMeds’ ePA solution with McKesson Specialty Health’s hub workflow helps reduce the administrative burden for providers while helping patients get the medication they need and improving outcomes.”
ExpressCoverage is part of McKesson Specialty Health’s portfolio of services for biopharma and life science companies. Leveraging proprietary technology and innovative solutions along the entire lifecycle of a drug, McKesson Specialty Health helps biopharma customers and partners bring life-changing medications to market and connect the patient to their therapies.
“Patients are our No. 1 priority, and we are constantly looking for ways to improve their experience and access to medications, from the first discussion with their physician to the point of picking up the prescription, followed by ongoing education and adherence support,” Bill Nolan, vice president and general manager, McKesson Specialty Health, said. “The real-time connectivity between the CoverMyMeds’ network of providers, payers and pharmacies, and McKesson’s hub support services will reduce barriers to access, help patients start therapy quickly and stay on therapy longer.”
The offering is the result of a collaboration between McKesson Specialty Health, a division of McKesson Corporation, and CoverMyMeds, part of McKesson Rx Technology Solutions and a leader in electronic prior authorization solutions. Express Coverage leverages the prior authorization expertise of CoverMyMeds and the broad spectrum of high-touch biopharma-sponsored McKesson services to help physicians and patients better navigate the complexities of a specialty therapy journey.
“Prior authorization, when done manually, often results in treatment delays and gaps in therapy for patients. The prior authorization process impacts approximately 300 million prescriptions each year, and of those, roughly 36% are abandoned,” Erica Conroy, vice president operations, CoverMyMeds, said. “The integration of CoverMyMeds’ ePA solution with McKesson Specialty Health’s hub workflow helps reduce the administrative burden for providers while helping patients get the medication they need and improving outcomes.”
ExpressCoverage is part of McKesson Specialty Health’s portfolio of services for biopharma and life science companies. Leveraging proprietary technology and innovative solutions along the entire lifecycle of a drug, McKesson Specialty Health helps biopharma customers and partners bring life-changing medications to market and connect the patient to their therapies.